TrialBritish journal of clinical pharmacology2018

First-in-man-proof of concept study with molidustat: a novel selective oral HIF-prolyl hydroxylase inhibitor for the treatment of renal anaemia.

M Böttcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.